Results 81 to 90 of about 21,592 (229)

Exacerbation of myasthenia gravis by alendronate

open access: yes, 2014
Myasthenia gravis is an important indication for the long-term prescription of corticosteroids. We present a patient with myasthenia gravis who had worsening of symptoms associated with the use of alendronate. A 24-year-old patient with myasthenia gravis
Yavuz, Ferdi   +4 more
core   +1 more source

Relationship between vitamin D deficiency and early implant failure and osseointegration

open access: yesPeriodontology 2000, EarlyView.
Abstract Background This systematic review investigated the relationship between pre‐operative vitamin D levels and implant osseointegration and implant‐related outcomes. It also assessed studies involving vitamin D supplementation before implant placement.
Richard J. Miron   +8 more
wiley   +1 more source

Supplement With Calcium or Alendronate Suppresses Osteopenia Due to Long Term Rabeprazole Treatment in Female Mice: Influence on Bone TRAP and Osteopontin Levels

open access: yesFrontiers in Pharmacology, 2020
Background and PurposeRabeprazole, a proton pump inhibitor (PPIs) is much endorsed to patients with increased gastric acidity. PPIs were accused to have osteoporotic effects on patients who chronically use them. The point of the current investigation was
Aly A.M. Shaalan   +11 more
doaj   +1 more source

The Effect of Alendronate in Male Osteoporosis

open access: yes, 2004
Osteoporosis in men is increasingly recognized as an important public health issue because of mortality and disability. Approximately 25-30% of all hip fractures occur in men and men are over 3 times more likely to die following a hip fracture than women.
Ebru Şahin   +8 more
core  

Synthesis and Characterization of an Alendronate-Chitosan Conjugate

open access: yes, 2011
The biomineral-binding alendronate-chitosan conjugate (Scheme 1) was developed as a novel drug delivery system. Alendronate was conjugated to the hydroxyl groups of chitosan, thereby maintaining the amino groups of chitosan intact.
Yan Peng Jiao   +3 more
core   +1 more source

Potentiometric determination of alendronate in pharmaceutical formulations

open access: yes, 2004
A simple, precise, fast and low-cost potentiometric method for alendronate determination in pharmaceutical formulations has been proposed. Alendronate present in tablets at the known concentration was potentiometrically titrated in an aqueous solution ...
Pezza, Leonardo   +2 more
core   +3 more sources

Alendronate-Induced Esophagitis: Possible Pathogenic Role of Hypersensitivity to Alendronate

open access: yesInternal Medicine, 2008
Upper gastrointestinal tract mucosal irritations, such as esophagitis, have been reported as rare adverse events due to a variety of aminobisphosphonates, including alendronate sodium, which have been widely used to treat osteoporosis. Although the pathogenesis of aminobisphosphonate-induced esophageal mucosal irritation has not been clearly understood,
Naniwa, Taio   +6 more
openaire   +3 more sources

Effects of non‐surgical periodontal therapy on intrabony periodontal defects at different re‐evaluation time points: A systematic review of randomized controlled trials and clinical recommendations

open access: yesPeriodontology 2000, EarlyView.
Abstract Objective The aim of this systematic review and meta‐analysis was to evaluate the longitudinal temporal pattern of periodontal probing depth (PPD) reduction in intrabony periodontal defects following non‐surgical periodontal therapy (NSPT), both as a monotherapy and with adjunctive locally delivered pharmacological agents.
Luca Ramaglia   +4 more
wiley   +1 more source

Alendronate improves QOL of postmenopausal women with osteoporosis

open access: yes, 2010
Hisaya Kawate1, Keizo Ohnaka2, Masahiro Adachi1, Suminori Kono3, Hideyuki Ikematsu4, Hisashi Matsuo5, Kazumi Higuchi6, Takehiko Takayama7, Ryoichi Takayanagi11Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu ...
Keizo Ohnaka   +3 more
core  

Alendronate-Modified Polymeric Micelles for the Treatment of Breast Cancer Bone Metastasis

open access: yes, 2019
Although the prognosis of patients with breast cancer continues to improve, breast cancer metastasis to bones remains high in incidence and challenging to manage.
Chi Zhang (9857)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy